However, in the HCV-negative AA/Black HCC patients, IFI6 mRNA levels were higher than those in HCV-positive White HCC patients, and in the HCV-positive AA/Black HCC patients, it was further augmented (Figure 3B,C). This evidence concerns the gene IFI6 and hepatocellular carcinoma.